Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Offer To Buy Genzyme Seen As Starting Point For Long Negotiation

This article was originally published in The Pink Sheet Daily

Executive Summary

French pharma's initial offer in the $67 to $70 per share range expected to rise, perhaps into the $80s.
Advertisement

Related Content

Diversification, Not Genzyme, Is The Theme Of Sanofi's Year-End Financial Report
Deals Of The Week: J&J/Crucell, Merck/Beijing Genomics Institute …
Court Backs FDA Rationale For Approving Generic Lovenox
Sanofi Turns The Screws On Genzyme
India Tightens Income Tax Noose On Sanofi-Aventis' Shantha Biotech Deal
Genzyme/Isis On Track To Submit Severe High Cholesterol Drug Mipomersen In 1H 2011
Pfizer's Focus Is On "Bolt-On" Acquisitions After Wyeth Merger
Sanofi Stays Mum On Genzyme But Near-Term M&A Appears Likely
Sanofi Stays Mum On Genzyme But Near-Term M&A Appears Likely
Orphaned No Longer: Big Pharma Embraces Drugs for Niche Markets

Topics

Advertisement
UsernamePublicRestriction

Register

PS071106

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel